IRCT20191203045594N1尚未招募2 期
To evaluate the efficacy and safety of adding metformin to chemoradiation of patients with squamous cell carcinoma of hypopharynx, nasopharynx, and larynx
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •All patients with biopsy-proven squamous cell carcinoma of hypopharynx, nasopharynx, and larynx
排除标准
- •All patients with distant metastasis
- •Hypersensitivity to metformin
研究者
相似试验
尚未招募
4 期
Comparing the benefits and safety of Metformin and Canthex® for treating dark skin patches in patients of Acanthosis NigricansCTRI/2024/08/071850Rutuja Angad Shinde
已完成
2 期
Comparison the effect of Metformin and Rosiglitazone, alone and in combination, to treat polycystic ovary syndrome.Polycystic ovarian syndrome.Polycystic ovarian syndromeIRCT201605257513N12Vice chancelor of research of Isfahan University of Medical Sciences44
已完成
4 期
A clinical trial to study the effects of two drugs, Metformin Immediate Release and Metformin Extended Release in newly diagnosed type 2 diabetes mellitus patients.CTRI/2021/04/033194Bangalore Medical College and Research Institute70
进行中（未招募）
不适用
To evaluate the effectiveness of MetaDerm Cream in Atopic DermatitisCTRI/2017/06/008950Haus Bioceuticals Inc
已完成
4 期
A study to compare the efficacy and adverse effects of metformin versus myoinositol plus d-chiroinositol combination therapy in polycystic ovarian syndromeCTRI/2019/03/018306Dr Sukhmani Jaura50